...
【24h】

Microcirculatory effects of selective receptor blockade during hemorrhagic shock treatment with vasopressin: Experimental study in the hamster dorsal chamber

机译:Microcirculatory选择性受体的影响出血性休克治疗期间封锁后叶加压素:仓鼠的实验研究背箱

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hemorrhagic shock is a major cause of death in modern societies. Some patients, when treated, fail to sustain normal cardiovascular parameters, requiring fluid therapy and vasoactive drugs. Among drugs with cardiovascular profile other than catecholamine, vasopressin (VP) is emerging as an option. To better understand its effects during hemorrhagic shock, we compared the effects of VP and noradrenaline (NA), associated to fluid therapy. In this work, hamsters were subjected to shock by withdrawal of 40% of their blood volume and were then divided into five groups. One group was treated with saline solution, and the remaining ones with VP (three groups) and NA (one group) combined to fluid resuscitation. To assess receptor role, two more VP groups were pretreated with specific receptor blockers (anti-V1 or anti-V 2, respectively) before its infusion. Microcirculatory parameters such as vessel diameter, red blood cell velocity, and functional capillary density were evaluated. In addition, blood gas analysis and lactate levels were also determined. Measurements were performed at baseline, after shock, and after treatment. At the end, leukocyte-endothelium interaction was evaluated, and animals were followed up to determine survival time. Neither saline solution nor NA recovered microcirculatory parameters, but VP treatment returned to near baseline values, except when V 2 receptors were blocked. Functional capillary density was higher in the VP group after treatment, without statistical difference from baseline values. When V 2 receptors were blocked, recovery was not achieved after treatment. The VP group also had a smaller number of adhering leukocytes and improved 72-h survival time compared with the NA one. This study suggests that, in hemorrhagic shock, treatment with low-dose VP, in combination with fluid therapy, improves tissue perfusion. This outcome is mediated mostly by V 2 receptors, eliciting vasodilatation and consequently blood flow redistribution through the microcirculation.
机译:出血性休克导致死亡的主要原因现代社会。无法维持正常心血管参数,要求液体治疗和血管活性的药物。在药物与其他心血管概要文件儿茶酚胺相比,加压素(VP)是新兴的作为一个选项。在出血性休克,我们比较了效果副总裁和去甲肾上腺素(NA),相关的流体治疗。冲击撤军的血容量的40%,然后被分成五组。用生理盐水治疗,剩余的(三组)和NA(一个副总裁液体复苏组)相结合。受体的作用,两个VP组进行预处理与特定的受体阻滞剂(anti-V1或分别为anti-V 2)注入之前。Microcirculatory船等参数直径、红细胞速度和功能毛细血管密度进行了评估。血气分析和乳酸水平也确定。基线,冲击后,治疗后。最后,leukocyte-endothelium交互评估和动物随访决定生存时间。和NA恢复microcirculatory参数,但是副总裁治疗回到基线值附近,除非V 2受体被封锁。实用毛细血管密度较高的副总裁组治疗后,没有统计从基线值的差异。受体被封锁,经济复苏并没有实现治疗后。秉承白细胞数量和提高72 - h生存时间与NA。研究表明,在出血性休克,用低剂量治疗副总裁,结合液体治疗,改善组织灌注。结果主要由V 2受体,介导引起血管舒张,因此血液通过微循环流再分配。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号